Cangrelor versus crushed ticagrelor in acute myocardial infarction complicated by cardiogenic shock (DAPT-SHOCK-AMI): a randomised, double-blind trial. // The Lancet. – URL: https://www.sciencedirect.com/science/article/pii/S0140673626009761?dgcid=rss_sd_all
Cangrelor versus crushed ticagrelor in acute myocardial infarction complicated by cardiogenic shock (DAPT-SHOCK-AMI): a randomised, double-blind trial. The Lancet. https://www.sciencedirect.com/science/article/pii/S0140673626009761?dgcid=rss_sd_all
“Cangrelor versus crushed ticagrelor in acute myocardial infarction complicated by cardiogenic shock (DAPT-SHOCK-AMI): a randomised, double-blind trial.” The Lancet.
@article{article101642,
title = {Cangrelor versus crushed ticagrelor in acute myocardial infarction complicated by cardiogenic shock (DAPT-SHOCK-AMI): a randomised, double-blind trial},
journal = {The Lancet},
url = {https://www.sciencedirect.com/science/article/pii/S0140673626009761?dgcid=rss_sd_all}
}
ABSTRACT As leadership education continues to evolve, increasing attention has been given to fostering learners’ leadership identity, capacity, and efficacy. Drawing on collaborative conversations with 12 leadership educators...